Semaphore CEO and leadership

Dr. James Coffin joined SourceMed in December of 2014 as the Chief Executive Officer, bringing with him a wealth of leadership experience in the healthcare and life sciences IT industries. Most recently, Dr. Coffin served as the Worldwide Vice-President, General Manager and Global Practice Leader of Dell's Healthcare and Life Sciences Division. In his six years at Dell, Dr. Coffin transformed the Dell business unit from a PC manufacturer in the HCLS industry into the world's leading provider of healthcare IT services and solutions. During his time at Dell, Dr. Coffin and his team worked closely with a wide variety of leaders in healthcare and life sciences, including major medical centers, academic institutions, major instrument vendors, payers and leading biotech and pharmaceutical companies. He pioneered Dell's efforts to apply leading edge information technology into areas including electronic medical records, data analytics, cloud computing, personalized medicine, claims processing, medical imaging and pharmaceutical and biotech drug discovery. Prior to Dell, Dr. Coffin held several senior leadership positions within IBM, including his last position as Worldwide Vice President for IBM's Healthcare and Life Sciences Industry. In this role, he focused primarily on strategy, worldwide sales, new business development and global partnerships. Dr. Coffin received his Bachelor of Science degree from Louisiana Tech University and a Ph.D. in Physical Chemistry from the University of Arkansas. He also attended Cambridge University as a Cambridge University Clare Hall Fulbright College Fellow.

Strategic and technical data science and biotechnology leader with 10 years of experience building and leading translational and research programs in data science, genetics, oncology, and precision medicine. Proven record building successful and durable programs across 4 institutions, including current executive leadership of a 700-person organization with over $100M annual budget that rose to become the #3 ranked genetics department in the country. Accomplished researcher as evidenced by 28 funded projects, an active publication record, and development of multiple widely used algorithms including one that ranked as the 2nd most influential computational biology algorithm in Google Scholar’s compilation of Classic Papers.

Andrew Kasarskis has more than 20 years of broad leadership experience in healthcare, biotech, and academia that includes a strong focus on digital analytics and internationally recognized life sciences research.

As Chief Data Officer (CDO), Andrew is responsible for further optimizing Sema4’s health intelligence platform and orchestrating data use and data science to support research, development, and innovation.

Prior to Sema4, Andrew most recently served as Executive Vice President and Chief Data Officer of the Mount Sinai Health System, including the Icahn School of Medicine at Mount Sinai, where he was responsible for supporting patient care, education, research, and innovation at Mount Sinai through purposeful and appropriate use of the health system’s data assets. Before assuming the CDO role at Mount Sinai, he worked with Founding Director Eric Schadt, now Sema4’s CEO, as Co-Director of the Icahn Institute for Genomics and Multiscale Biology and Vice Chair of the Department of Genetics and Genomic Sciences, in which he also served as Interim Chair.

Dr. Kasarskis’ collaborative research as Professor in the Departments of Genetics and Genomic Sciences and Population Health Science and Policy at the Icahn School of Medicine at Mount Sinai focused on methods and technologies for improving health outcomes through better data acquisition and mining to support patient care decisions and therapeutic and diagnostic development. He created and applied technology across many disease and public health areas including pathogen surveillance, autoimmune conditions such as inflammatory bowel disease and asthma, viral infections, and primary prevention of chronic disease.

Prior to Mount Sinai, Andrew held leadership positions at Pacific Biosciences, Sage Bionetworks and Merck. He has published more than 90 research papers.

Andrew holds a PhD in Molecular and Cellular Biology from the University of California, Berkeley, as well as a B.S. in Biology and a B.A. in Chemistry from the University of Kentucky.

Alan B. Copperman, M.D. is the Director of the Division of Reproductive Endocrinology and Infertility and the Vice-Chairman of the Department of Obstetrics, Gynecology and Reproductive Science at The Icahn School of Medicine at Mount Sinai. Dr. Copperman was a co-founder and serves as Medical Director of RMA of New York, one of the largest and most prestigious IVF Centers in the country. He is an experienced and respected clinician, and has a long history of achieving success in treating infertility and in applying fertility preservation technologies. He has published numerous manuscripts and book chapters on reproductive medicine, and has co-authored hundreds of scientific abstracts on infertility, in vitro fertilization, egg freezing, ovum donation, and genetics. Dr. Copperman is frequently quoted in print and digital media, including the Associated Press, Wall Street Journal, U.S. News & World Report, The New York Times, WebMD, SELF, Health.com, Parenting magazine, Parents.com, and Refinery29. He has been featured on local and nationally-televised news shows, including Fox 5 NY Live, CBS This Morning, Huffington Post Live, Anderson Cooper 360, and 20/20. Dr. Copperman was named to New York magazine’s list of Best Doctors sixteen years in a row. He has been recognized annually by Castle Connolly and SuperDocs as one of the top fertility doctors and by his peers and patient advocacy organizations for his commitment to patient-focused and data-driven care.

Garth Brown is a President Ex-Officio at King County Search And Rescue Association and President & COO at Semaphore and is based in Mercer Island, Washington.